Several studies support the evidence that inhibition of myeloid cell migration by IFN-γ in vivo serves to restrain infiltration of inflamed tissues and control associated tissue damage, thereby attenuating the severity of disease models of human autoimmune diseases. This evidence concerns the gene IFNG and autoimmune disease.